Keywords: وارفارین; Acute ischemic stroke; deep venous thrombosis; Trousseau's syndrome; lung cancer; warfarin; heparin
مقالات ISI وارفارین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: وارفارین; Prothrombin complex concentrates; Anticoagulation; Trauma; Warfarin; Reversal; Geriatric
Keywords: وارفارین; Anticoagulants; Congestive heart failure; Pharmacogenomics; Warfarin
Keywords: وارفارین; ADP receptor antagonists; dabigatran; fondaparinux; glycoprotein IIb/IIIa antagonists; heparin; rivaroxaban; warfarin
Keywords: وارفارین; Venous thromboembolism; Warfarin; Enoxaparin; Total knee replacement; Iran
Keywords: وارفارین; Gingko; Warfarin; Overweight; Diabetes; Text query; Structured data; Cohort identification; Unstructured data; Clinical notes
Keywords: وارفارین; Pharmacogenomics; Patient education; Warfarin; Individualized medicine
Keywords: وارفارین; anticoagulation; thromboembolism; perioperative; best practice; warfarin; low-molecular-weight heparin
Keywords: وارفارین; Novel oral anticoagulants; Atrial fibrillation; Warfarin; Dabigatran; RivaroxabanAF, atrial fibrillation; CHADS2, cardiac failure, hypertension, age, diabetes, stroke (doubled); CHA2DS2-VASc, congestive heart failure, hypertension, age ≥75 years (doubled)
Reduced-Intensity Anticoagulation for Mechanical Aortic Valve Prosthesesâ
Keywords: وارفارین; anticoagulation; mechanical heart valve; warfarin;
Pharmacogenetic Labeling of FDA-Approved Drugs
Keywords: وارفارین; drug labeling; pharmacogenomics; precision medicine; regulatory perspective; warfarin;
Effects of home prothrombin international ratio (PT-INR) management in children with mechanical prosthetic valves - Importance of individual correlations between laboratory and CoaguChek device PT-INRs
Keywords: وارفارین; Warfarin; Prothrombin time; Home management; Prosthetic valve; Safety;
Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa
Keywords: وارفارین; Warfarin; Prothrombin complex concentrate; Reversal; Recombinant factor VIIa; Anticoagulation;
Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
Keywords: وارفارین; Deep vein thrombosis; Post-thrombotic syndrome; Quality of life; Rivaroxaban; Warfarin;
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
Keywords: وارفارین; AF; atrial fibrillation; CI; confidence interval; DCCV; direct current cardioversion; NOAC; non-vitamin K antagonist oral anticoagulant; OR; odds ratio; TEE; transesophageal echocardiography; TIA; transient ischemic attack; RCT; randomized controlled tria
Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation
Keywords: وارفارین; Atrial fibrillation; Novel oral anticoagulants; Warfarin; Direct current cardioversion procedures;
Elective Cardioversion in the Era of Novel Oral Anticoagulants - Does a Nurse Administered Verbal Questionnaire for Compliance Negate the Need for Routine Transoesophageal Echocardiography?
Keywords: وارفارین; EDCCV; External direct current cardioversion; NOAC; Novel oral anticoagulant; TOE; Transoesophageal echocardiogram; SSE; Stroke or systemic embolism; EPCNC; Electrophysiology clinical nurse consultant; Compliance; External cardioversion; Atrial fibrillati
Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study
Keywords: وارفارین; Warfarin; Vitamin- K antagonists; Direct oral anticoagulant; DOAC; Adherence; Patient care; Atrial fibrillation; Venous thromboembolism; Quality of life;
Registry of Japanese patients with atrial fibrillation focused on anticoagulant therapy in the new era: The RAFFINE registry study design and baseline characteristics
Keywords: وارفارین; Atrial fibrillation; Direct oral anticoagulants; Warfarin; RAFFINE registry;
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Keywords: وارفارین; AF; atrial fibrillation; AKI; acute kidney injury; CHA2DS2-VASc; congestive heart failure, hypertension, aged 75â¯years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, aged 65 to 74â¯years, female; CKD; chronic
Factores pronósticos y análisis de la mortalidad de las hemorragias cerebrales asociadas a anticoagulantes orales antagonistas de la vitamina K. Resultados del Estudio TAC Registry
Keywords: وارفارین; Hemorragia cerebral; Anticoagulantes orales; Acenocumarol; Warfarina; Mortalidad; Intracranial haemorrhage; Oral anticoagulants; Acenocoumarol; Warfarin; Mortality;
Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC Registry
Keywords: وارفارین; Intracranial haemorrhage; Oral anticoagulants; Acenocoumarol; Warfarin; Mortality; Hemorragia cerebral; Anticoagulantes orales; Acenocumarol; Warfarina; Mortalidad;
Quantifying low levels (<0.5% w/w) of warfarin sodium salts in oral solid dose forms using Transmission Raman spectroscopy
Keywords: وارفارین; Transmission Raman; Warfarin; Raman spectroscopy; Crystallinity; Polymorphism;
Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS)
Keywords: وارفارین; Dried blood spots; Warfarin; Warfarin alcohol metabolites; Liquid extraction; UHPLC-MS/MS;
Investigation of hepatic warfarin metabolism activity in rodenticide-resistant black rats (Rattus rattus) in Tokyo by in situ liver perfusion
Keywords: وارفارین; Warfarin; Rodenticide resistance; Rattus rattus; Liver perfusion; Metabolism; Cytochrome P450;
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke
Keywords: وارفارین; Stroke volume; recurrent; NOAC; DOAC; direct thrombin inhibitor; dabigatran; factor Xa inhibitor; rivaroxaban; apixaban; edoxaban; warfarin;
Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study
Keywords: وارفارین; Acenocoumarol; Vitamin K antagonists; Anticoagulation; Atrial fibrillation; Internal Medicine; Neurology; Warfarin; Acenocumarol; Antagonistas de la vitamina K; Anticoagulación; Fibrilación auricular; Medicina Interna; NeurologÃa; Warfarina;
Factores asociados al mal control de la anticoagulación con antivitamina K en pacientes con fibrilación auricular no valvular atendidos en consultas de Medicina Interna y NeurologÃa. Estudio ALADIN
Keywords: وارفارین; Acenocumarol; Antagonistas de la vitamina K; Anticoagulación; Fibrilación auricular; Medicina Interna; NeurologÃa; Warfarina; Acenocoumarol; Vitamin K antagonists; Anticoagulation; Atrial fibrillation; Internal Medicine; Neurology; Warfarin;
Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal
Keywords: وارفارین; acetylsalicylic acid; clopidogrel; prasugrel; ticagrelor; dabigatran; rivaroxaban; apixaban; warfarin; heparin; low molecular weight heparin; proton pump inhibitors; Bleeding; Chronic kidney disease; Management; Risk;
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism
Keywords: وارفارین; Anticoagulants; Frailty; Rivaroxaban; Venous thromboembolism; Warfarin;
Synthesis and characterization of novel trimethyltin(IV) and tributylltin(IV) complexes of anticoagulant, WARFARIN: Potential DNA binding and plasmid cleaving agents
Keywords: وارفارین; Warfarin; Organotin(IV); DNA-binding; Partial intercalation; Gel electrophoresis;
Weight and the vitamin K expoxide reductase 1 genotype primarily contribute to the warfarin dosing in pediatric patients with Kawasaki disease
Keywords: وارفارین; KD; Kawasaki disease; CAA; coronary artery aneurysm; GCAA; giant coronary artery aneurysm; INR; international normalized ratio; SNP; single nucleotide polymorphism; VKORC1; vitamin K expoxide reductase; CYP2C9; cytochrome P4502C9; BSA; body surface area;
Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms
Keywords: وارفارین; Venous thromboembolism; Vitamin K antagonists; Acenocoumarol; Warfarin; Genetic polymorphisms; AF; atrial fibrillation; APOE; apolipoprotein E; AUC; area under the curve; CI; confidence interval; CRNM bleeding; clinically relevant non-major bleeding; CYP2
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
Keywords: وارفارین; Anticoagulants; Cancer; Low-molecular-weight heparin; Thromboembolism; Warfarin;
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
Keywords: وارفارین; Anticoagulation; Apixaban; Atrial fibrillation; Bleeding; History of falls; Stroke; Warfarin;
Peri-Procedural Management of Oral Anticoagulants in the DOAC Era
Keywords: وارفارین; Oral anticoagulant; Direct oral anticoagulant (DOAC); Warfarin; Peri-procedural management;
Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism
Keywords: وارفارین; Deep venous thrombosis; Oral anticoagulation; Post-thrombotic syndrome; Rivaroxaban; Warfarin;
Enhanced visible light photodegradation of pharmaceutical pollutant, warfarin by nano-sized SnTe, effect of supporting, catalyst dose, and scavengers
Keywords: وارفارین; Pharmaceutical pollutant; Warfarin; Photodegradation; SnTe; SBA-15; SnTe@SBA-15;
A simple, sensitive, and high-throughput LC-APCI-MS/MS method for simultaneous determination of vitamin K1, vitamin K1 2,3-epoxide in human plasma and its application to a clinical pharmacodynamic study of warfarin
Keywords: وارفارین; VK1; vitamin K1; VK1O; vitamin K1 2,3-epoxide; VKOR; vitamin K epoxide reductase; VKORC1; vitamin K epoxide reductase complex subunit 1; IS; internal standard; S/N; signal-to-noise ratio; GGCX; gamma-glutamyl carboxylase; Glu; glutamic acid; Gla; gamma ca
Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
Keywords: وارفارین; Apixaban (CID: 10182969); Betrixaban (CID: 10275777) dabigatran etexilate (CID: 216210); Edoxaban (CID: 10280735); Rivaroxaban (CID: 9875401); Warfarin (CID:â54678486); Apixaban; Betrixaban; Dabigatran etexilate; Edoxaban; Rivaroxaban; Warfarin;
Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: A single-center observational study
Keywords: وارفارین; Atrial fibrillation; Dabigatran; Japanese; Stroke; Warfarin;
Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience
Keywords: وارفارین; Atrial fibrillation; Cardioversion; Non-VKA oral anticoagulants; Stroke; Warfarin;
Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
Keywords: وارفارین; Atrial fibrillation; Catheter ablation; Warfarin; Direct oral anticoagulant;
Meta-analysis of major bleeding events on aspirin versus vitamin K antagonists in randomized trials
Keywords: وارفارین; Vitamin K antagonists; Warfarin; Aspirin; Bleeding; Meta-analysis;
Vitamin K epoxide reductase expression and prostate cancer risk
Keywords: وارفارین; Prostate cancer; Vitamin K epoxide reductase; Warfarin;
Full Length ArticleFactors influencing warfarin control in Australia and Singapore
Keywords: وارفارین; Warfarin; Atrial fibrillation; International normalised ratio;
Cirurgia da mão e do punho sem suspender varfarina ou antiplaquetários orais - Revisão sistemática
Keywords: وارفارین; Mão/cirurgia; Anticoagulantes; Varfarina; Hand/surgery; Anticoagulants; Warfarin;
Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials
Keywords: وارفارین; Non-vitamin K antagonist (NOAC); Warfarin; Effectiveness; Safety; Atrial fibrillation (AF); Time in therapeutic range (TTR);
AJM onlineClinical research studyImproving Warfarin Management Within the Medical Home: A Health-System Approach
Keywords: وارفارین; Anticoagulants; Patient-centered care; Primary health care; Warfarin;
The Sex, Age, Medical History, Treatment, Tobacco Use, Race Risk (SAMe TT2R2) Score Predicts Warfarin Control in a Singaporean Population
Keywords: وارفارین; Warfarin; predictor model; anticoagulant; atrial fibrillation;